CTIX is essentially flat to slightly up since Trump made negative comments yesterday about pharma at his news conference, The biotech index is down about 4% since that time, this demonstrates that the new trend is up, other things being equal.
I think, based purely on what seems to me to be slow enrollment data for a condition that affects 400,000 people a year in USA, that OM is the weaker of the ongoing trial candidates so that could be a factor in the stock currently being in the doldrums . Expect a large upside breakout if OM has even moderately good news.